Murine monoclonal anti-tNF antibody administration has a beneficial effect on inflammatory bowel disease that develops in IL-10 knockout mice.

Interleukin-10-deficient mice develop chronic enterocolitis

1993 • 4,225 citations

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

1997 • 3,152 citations

Anti-Inflammatory Cytokines

2000 • 1,613 citations

Experimental models of inflammatory bowel disease

1995 • 1,215 citations

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

1996 • 1,128 citations

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

1999 • 1,107 citations

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

1999 • 771 citations

Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1999 • 755 citations

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

1992 • 700 citations

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

1991 • 491 citations

Helicobacter hepaticusTriggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism

1998 • 449 citations

Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis.

1990 • 447 citations

Antibiotic therapy attenuates colitis in interleukin 10 gene–deficient mice

2000 • 231 citations

The relationship between infliximab treatment and lymphoma in Crohn's disease

1999 • 208 citations

EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE

1986 • 199 citations

Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.

1992 • 169 citations

Permeability of the rat small intestinal epithelium along the villus-crypt axis: Effects of glucose transport

2000 • 152 citations

Enhanced mucosal cytokine production in inflammatory bowel disease

1992 • 151 citations

Infliximab approved for use in Crohn's disease: A report on the fda gi advisory committee conference

1998 • 105 citations

Antibodies to tumour necrosis factor α as treatment for Crohn's disease

2000 • 101 citations

Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy.

1993 • 98 citations

Biologic therapy for inflammatory bowel disease

1997 • 58 citations